| A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses K Esposito, MI Maiorino, G Bellastella, P Chiodini, D Panagiotakos, ... BMJ open 5 (8), e008222, 2015 | 460 | 2015 |
| Diabetes and sexual dysfunction: current perspectives MI Maiorino, G Bellastella, K Esposito Diabetes, metabolic syndrome and obesity: targets and therapy, 95-105, 2014 | 398 | 2014 |
| Lymphocytic hypophysitis: a rare or underestimated disease? A Bellastella, A Bizzarro, C Coronella, G Bellastella, AA Sinisi, A De Bellis European Journal of Endocrinology 149 (5), 363-376, 2003 | 256 | 2003 |
| Determinants of female sexual dysfunction in type 2 diabetes K Esposito, MI Maiorino, G Bellastella, F Giugliano, M Romano, ... International journal of impotence research 22 (3), 179-184, 2010 | 217 | 2010 |
| Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis K Esposito, P Chiodini, A Capuano, G Bellastella, MI Maiorino, E Parretta, ... Journal of endocrinological investigation 36, 132-139, 2013 | 216 | 2013 |
| Metabolic syndrome and endometrial cancer: a meta-analysis K Esposito, P Chiodini, A Capuano, G Bellastella, MI Maiorino, ... Endocrine 45, 28-36, 2014 | 214 | 2014 |
| Determinants of erectile dysfunction in type 2 diabetes F Giugliano, M Maiorino, G Bellastella, M Gicchino, D Giugliano, ... International Journal of Impotence Research 22 (3), 204-209, 2010 | 204 | 2010 |
| Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis K Esposito, P Chiodini, A Capuano, G Bellastella, MI Maiorino, ... Endocrine 44, 634-647, 2013 | 199 | 2013 |
| The effects of a Mediterranean diet on the need for diabetes drugs and remission of newly diagnosed type 2 diabetes: follow-up of a randomized trial K Esposito, MI Maiorino, M Petrizzo, G Bellastella, D Giugliano Diabetes care 37 (7), 1824-1830, 2014 | 191 | 2014 |
| Proportion of patients at HbA1c target< 7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients K Esposito, P Chiodini, G Bellastella, MI Maiorino, D Giugliano Diabetes, Obesity and Metabolism 14 (3), 228-233, 2012 | 179 | 2012 |
| Antipituitary antibodies after traumatic brain injury: is head trauma-induced pituitary dysfunction associated with autoimmunity? F Tanriverdi, A De Bellis, A Bizzarro, AA Sinisi, G Bellastella, E Pane, ... European Journal of Endocrinology 159 (1), 7-13, 2008 | 172 | 2008 |
| Efficacy of Insulin Analogs in Achieving the Hemoglobin A1c Target of <7% in Type 2 Diabetes: Meta-analysis of randomized controlled trials D Giugliano, MI Maiorino, G Bellastella, P Chiodini, A Ceriello, K Esposito Diabetes care 34 (2), 510-517, 2011 | 169 | 2011 |
| Which diet for prevention of type 2 diabetes? A meta-analysis of prospective studies K Esposito, P Chiodini, MI Maiorino, G Bellastella, D Panagiotakos, ... Endocrine 47, 107-116, 2014 | 159 | 2014 |
| Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis K Esposito, P Chiodini, A Capuano, G Bellastella, MI Maiorino, ... Menopause 20 (12), 1301-1309, 2013 | 158 | 2013 |
| Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials MI Maiorino, S Signoriello, A Maio, P Chiodini, G Bellastella, ... Diabetes Care 43 (5), 1146-1156, 2020 | 155 | 2020 |
| Mediterranean diet for type 2 diabetes: cardiometabolic benefits K Esposito, MI Maiorino, G Bellastella, DB Panagiotakos, D Giugliano Endocrine 56, 27-32, 2017 | 147 | 2017 |
| Dipeptidyl peptidase‐4 inhibitors and HbA1c target of< 7% in type 2 diabetes: meta‐analysis of randomized controlled trials K Esposito, D Cozzolino, G Bellastella, MI Maiorino, P Chiodini, A Ceriello, ... Diabetes, Obesity and Metabolism 13 (7), 594-603, 2011 | 143 | 2011 |
| Lifestyle modifications and erectile dysfunction: what can be expected? MI Maiorino, G Bellastella, K Esposito Asian Journal of Andrology 17 (1), 5, 2015 | 130 | 2015 |
| Diabetes and aging: from treatment goals to pharmacologic therapy M Longo, G Bellastella, MI Maiorino, JJ Meier, K Esposito, D Giugliano Frontiers in Endocrinology 10, 45, 2019 | 125 | 2019 |
| Insulin and glucagon-like peptide 1 receptor agonist combination therapy in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials MI Maiorino, P Chiodini, G Bellastella, A Capuano, K Esposito, ... Diabetes Care 40 (4), 614-624, 2017 | 125 | 2017 |
